目前的吸烟状况与 COVID-19 无关。
Current smoking is not associated with COVID-19.
机构信息
Clinica Medica 3, Dept of Medicine - DIMED, University-Hospital of Padova, Padova, Italy
Clinica Medica 3, Dept of Medicine - DIMED, University-Hospital of Padova, Padova, Italy.
出版信息
Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.01290-2020. Print 2020 Jun.
Abstract
摘要
相似文献
1
Current smoking is not associated with COVID-19.目前的吸烟状况与 COVID-19 无关。
Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.01290-2020. Print 2020 Jun.
2
Smoking, ACE-2 and COVID-19: ongoing controversies.吸烟、ACE-2 和 COVID-19：持续存在的争议。
Eur Respir J. 2020 Jul 16;56(1). doi: 10.1183/13993003.01759-2020. Print 2020 Jul.
3
COVID-19 and smoking: is nicotine the hidden link?新型冠状病毒肺炎与吸烟：尼古丁是隐藏的关联吗？
Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.01116-2020. Print 2020 Jun.
4
COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?新冠病毒和电子烟：增加感染 SARS-CoV-2 风险？
Eur Respir J. 2020 Jul 16;56(1). doi: 10.1183/13993003.01645-2020. Print 2020 Jul.
5
Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19.慢性阻塞性肺疾病和吸烟对 COVID-19 结局的影响。
Int J Tuberc Lung Dis. 2020 Aug 1;24(8):838-843. doi: 10.5588/ijtld.20.0278.
6
COVID-19 and nicotine as a mediator of ACE-2.新型冠状病毒肺炎与尼古丁作为 ACE-2 的中介
Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.01261-2020. Print 2020 Jun.
7
Reply to: "Current smoking is not associated with COVID-19".回复：“当前吸烟与 COVID-19 无关”。
Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.01340-2020. Print 2020 Jun.
8
Nebulized Therapy in the COVID-19 Era: The Right Tool for the Right Patient [Letter].新冠疫情时代的雾化治疗：适用于合适患者的正确工具[信函]
Int J Chron Obstruct Pulmon Dis. 2020 Sep 7;15:2101-2102. doi: 10.2147/COPD.S272382. eCollection 2020.
9
Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2?抗击 COVID-19 的“罪魁祸首”会不会是（rh）ACE-2？
Eur Respir J. 2020 Jul 16;56(1). doi: 10.1183/13993003.01560-2020. Print 2020 Jul.
10
Covid-19 and COPD: A Personal Reflection.新冠病毒与慢性阻塞性肺疾病：个人反思
Int J Chron Obstruct Pulmon Dis. 2020 Apr 24;15:883-884. doi: 10.2147/COPD.S255101. eCollection 2020.
引用本文的文献
1
ACE-2 blockade and TMPRSS2 inhibition mitigate SARS-CoV-2 severity following cigarette smoke exposure in airway epithelial cells .在气道上皮细胞中，抑制血管紧张素转换酶2（ACE-2）和跨膜丝氨酸蛋白酶2（TMPRSS2）可减轻香烟烟雾暴露后新型冠状病毒肺炎（SARS-CoV-2）的严重程度。
Mol Ther Nucleic Acids. 2025 Jun 2;36(3):102580. doi: 10.1016/j.omtn.2025.102580. eCollection 2025 Sep 9.
2
COVID-19 Predictors of Morbidity and Mortality.COVID-19 发病率和死亡率的预测因素
Cureus. 2024 Apr 25;16(4):e59017. doi: 10.7759/cureus.59017. eCollection 2024 Apr.
3
Risk factors for COVID-19 in-hospital mortality in Argentina: A competing risk survival analysis.阿根廷 COVID-19 住院死亡率的风险因素：一项竞争风险生存分析。
PLOS Glob Public Health. 2024 Jan 5;4(1):e0000816. doi: 10.1371/journal.pgph.0000816. eCollection 2024.
4
Carbon dioxide and MAPK signalling: towards therapy for inflammation.二氧化碳与 MAPK 信号转导：炎症治疗的新靶点
Cell Commun Signal. 2023 Oct 10;21(1):280. doi: 10.1186/s12964-023-01306-x.
5
Nontoxic Levels of Se-Containing Compounds Increase Survival by Blocking Oxidative and Inflammatory Stresses via Signal Pathways Whereas High Levels of Se Induce Apoptosis.无毒水平的含硒化合物通过信号通路阻断氧化应激和炎症应激从而提高存活率，而高水平的硒则诱导细胞凋亡。
Molecules. 2023 Jul 5;28(13):5234. doi: 10.3390/molecules28135234.
6
Predictive value of multiple variable models including nutritional risk score (NRS 2002) on mortality and length of stay of patients with covid-19 infections. The INCOVO study.多变量模型（包括营养风险评分（NRS 2002））对 COVID-19 感染患者死亡率和住院时间的预测价值。INCOVO 研究。
Clin Nutr ESPEN. 2023 Jun;55:357-363. doi: 10.1016/j.clnesp.2023.04.001. Epub 2023 Apr 11.
7
Examining Disparities in Current E-Cigarette Use among U.S. Adults before and after the WHO Declaration of the COVID-19 Pandemic in March 2020.分析 2020 年 3 月世界卫生组织宣布 COVID-19 大流行前后美国成年人当前电子烟使用情况的差异。
Int J Environ Res Public Health. 2023 Apr 26;20(9):5649. doi: 10.3390/ijerph20095649.
8
Current tobacco use and SARS-CoV-2 infection in two Norwegian population-based cohorts.当前烟草使用与 2 项挪威基于人群队列研究中的 SARS-CoV-2 感染。
BMC Public Health. 2023 May 10;23(1):846. doi: 10.1186/s12889-023-15822-5.
9
Cigarette smoke preferentially induces full length ACE2 expression in differentiated primary human airway cultures but does not alter the efficiency of cellular SARS-CoV-2 infection.香烟烟雾优先诱导分化的原代人气道培养物中全长血管紧张素转换酶2（ACE2）的表达，但不改变细胞感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的效率。
Heliyon. 2023 Mar;9(3):e14383. doi: 10.1016/j.heliyon.2023.e14383. Epub 2023 Mar 11.
10
E-Cigarette Vapour Increases ACE2 and TMPRSS2 Expression in a Flavour- and Nicotine-Dependent Manner.电子烟蒸汽以风味和尼古丁依赖的方式增加 ACE2 和 TMPRSS2 的表达。
Int J Environ Res Public Health. 2022 Nov 13;19(22):14955. doi: 10.3390/ijerph192214955.
本文引用的文献
1
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19.吸烟者和 COPD 患者小气道上皮中的 ACE-2 表达：对 COVID-19 的影响。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00688-2020. Print 2020 May.
2
Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.新冠病毒肺炎住院患者基础疾病的患病率：一项系统评价与Meta分析
Arch Acad Emerg Med. 2020 Mar 24;8(1):e35. eCollection 2020.
3
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响：一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
4
Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19).主动吸烟与2019冠状病毒病（COVID-19）的严重程度无关。
Eur J Intern Med. 2020 May;75:107-108. doi: 10.1016/j.ejim.2020.03.014. Epub 2020 Mar 16.
5
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
6
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
Zotero 插件